Skip to content

Ropivacaine for pain management in patients who undergo Caesarean section

Preperitoneal ropivacaine in the management of postoperative pain in post-Caesarean section patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15849443
Enrollment
82
Registered
2022-05-24
Start date
2018-10-17
Completion date
Unknown
Last updated
2022-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative pain management in patients who undergo cesarean section Pregnancy and Childbirth C-section

Interventions

The patients were randomly assigned, by simple random sampling, into two groups (A and B), in accordance with a table of random numbers. Preperitoneal ropivacaine was administered in group A, while gr

Sponsors

Mexican Social Security Institute
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women from 18 to 40 years of age 2. Term pregnancy 3. Undergoing programmed or elective cesarean section

Exclusion criteria

Exclusion criteria: 1. Chronic diseases 2. Placental disorders 3. Infections 4. Aallergies to anesthetics 5. Contraindication to regional anesthesia 6. Obstetric emergency 7. History of drug abuse 8. Inability to understand the visual analog scale

Design outcomes

Primary

MeasureTime frame
Pain was measured using the VAS scale at the end of the surgery (baseline), 2, 6, 12, 18 and 24 hours after surgery.

Secondary

MeasureTime frame
1.Use of rescue doses was measured using the VAS scale at the end of the surgery (baseline), 2, 6, 12, 18 and 24 hours after surgery. 2. Days of hospital stay were measured using the medical record over a 10 day period after the surgery 3. Presence of adverse events was measured using medical examination over a 10 day period after the surgery

Countries

Mexico

Contacts

Public ContactGloria Patricia Sosa Bustamante
patriciasosab@hotmail.com+52 477 7174800 Ext: 31804

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026